Dysfunction of parathyroids in patients on regular dialysis treatment and after kidney transplantation;Poruchy funkce příštítných tělǐsek u nemocných v pravidelném dialyzačním léčení a po transplantaci ledviny

Casopis Lekaru Ceskych

Volumn 142, Issue 4, 2003, Pages 229-234

  Sotorník, Ivo ^a   Bubenicek P ^a   Adamec, M ^a   Karasova L ^a   Povysil J ^b   Skibova J ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Hemodialysis; Hyperparathyroidism; Hypoparathyroidism; Parathyroid gland implantations; Parathyroid hormone; Parathyroidectomy; Renal transplantation

Indexed keywords

PARATHYROID HORMONE;

ARTICLE; CONTROLLED STUDY; CRYOPRESERVATION; DIALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; HYPERPARATHYROIDISM; HYPOPARATHYROIDISM; IMPLANTATION; KIDNEY TRANSPLANTATION; LABORATORY TEST; MAJOR CLINICAL STUDY; PARATHYROID DISEASE; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; POSTOPERATIVE PERIOD; RECURRENT DISEASE; RENAL OSTEODYSTROPHY; RISK; TREATMENT INDICATION; ADOLESCENT; ADULT; AGED; AUTOTRANSPLANTATION; FEMALE; MALE; MIDDLE AGED; PARATHYROID GLAND; RENAL REPLACEMENT THERAPY; SECONDARY HYPERPARATHYROIDISM; TRANSPLANTATION;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; HYPOPARATHYROIDISM; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PARATHYROID GLANDS; PARATHYROIDECTOMY; RENAL DIALYSIS; TRANSPLANTATION, AUTOLOGOUS;

EID: 0038674742     PISSN: 00087335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Monier-Faugere, M.-C., Malluche, H. H.: Trends in renal osteodystrophy: a survey from 1983 to 1995 in a total of 2248 patients. Nephrol. Dial. Transplant., 11, 1996 (Suppl. 3), s. 111-120.
2. Lachmanová, J.: Statistická ročenka dialyzační léčby v České republice 1999. Janssen-Cilag, ČR, Praha 2000.
3. Yano, S., Sugimoto, T., Tsukamoto, T. et al.: Association of decreased calcium-sensing receptor expression with proliferation of parathyroid cells in secondary hyperparathyroidism. Kidney Int., 58, 2000, s. 1980-1986.
4. Cayco, A. V., Wysolmerski, J., Simpson, C. H. et al.: Post-transplant bone disease: evidence for high bone resorption intake. Transplantation, 70, 2000, s. 1722-1728.
5. Salusky, I. B., Goodman, W. G.: Adynamic renal osteodystrophy: Is there a problem? J. Am. Nephrol., 12, 2001, s. 1978-1985.
6. 3 of transcription of the pre-proparathyroid hormone gene. Endocrinology, 119, 1986, s. 2864-2866.
7. Goodman, W. G., Ramirez, J. A., Belin, T. R. et al.: Development of adynamic bone disease in patients with secondary hyperparathyroidism after intermittent calcitriol therapy. Kidney Int., 46, 1994, s. 1160-1166.
8. Monier-Faugere, M.-C., Geng, Z., Maward, H. et al.: Improved assessment of bone turnover by the PTH - (1-84)/large C-PTH fragments ratio in ESRD patients. Kidney Int., 60, 2001, s. 1460-1468.
9. Felsenfeld, A.J.: Considerations for the treatment of secondary hyperparathyroidism in renal failure. J. Am. Soc. Nephrol., 8, 1997, s. 993-1004.
10. Brossard, J. H., Cloutier, M., Roy, L. et al.: Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: Importance in the interpretation of PTH values. J. Clin. Endocrinol. Metab., 81, 1996, s. 3923-3929.
11. Divieti, P., Inomata, N., Chapin, K. et al.: Receptors for carboxyl-terminal region of PTH (1-84) are highly expressed in osteocytic cells. Endocrinology, 137, 2001, s. 916-925.
12. Jarava, C., Armas, J. R., Salgueira, M., Palma, A.: Bone alkaline phosphatase isoenzyme in renal osteodystrophy. Nephrol. Dial. Transplant., 11, 1996 (Suppl. 3), s. 43-46.
13. Adamec, M., Sotorník, I., Bubeníček, P. et al.: Chirurgická léčba hyperparatyreózy - naše zkušenosti. Rozhl. Chir., 10, 2002, s. 516-518.
14. Kobylka, P., Bubeníček, P., Sotorník, I.: Kryokonzervace tkáně příštítných tělísek, možnosti reimplantace a transplantace. In: Sotorník, I., Táborský, P. (ed.). Nejnovější poznatky v renální osteopatii. Abbott Laboratories, Praha 2000, s. 137-142.
15. Fukagawa, M., Tominaga, Y., Kitaoka, M. et al.: Medical and surgical aspects of parathyroidectomy. Kidney Int., 56, 1999 (Suppl. 73), s. 65-69.
16. Slatopolsky, E., Weerts, C., Thielan, J. et al.: Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients. J. Clin. Invest., 74, 1984, s. 2136-2143.
17. Türk, S., Akbulut, M., Yildiz, A. et al.: Comparative effect of oral pulse and intravenous calcitriol treatment in haemodialysis patients. The effect on serum IL-1 and IL-6 levels and bone mineral density. Nephron, 90, 2002, s. 188-194.
18. Antonsen, J.E., Sherrard, D.J., Andress, D.L.: A calcimimetic agent actualy supresses parathyroid hormone levels in patients with chronic renal failure. Kidney Int., 53, 1998, s. 223-227.
19. Cohen, E. P., Moulder, J. E.: Parathyroidectomy in chronic renal failure: Has medical care reduced the need for surgery? Nephron, 89, 2001, s. 271-273.
20. Sotorník, I., Petrásek, R., Schück, O. et al.: Nárazové dávky kalcitriolu při léčení sekundární hyperparatyreózy u hemodialyzovaných nemocných. Vnitř. Lék., 43, 1997, s. 584-591.
21. Schömig, M., Ritz, E.: Management of disturbed calcium metabolism in uraemic patients: 2. Indications for parathyroidectomy. Nephrol. Dial. Transplant., 15, 2000 (Suppl. 5), s. 25-29.
22. Reichel, H.: Medical management of renal hyperparathyroidism: Pulse treatment with vitamin D metabolites or not? Nephrol. Dial. Transplant., 9, 1994, s. 1348-1370.
23. Sotorník, I., Kočandrle, V.: Naše zkušenosti s chirurgickým léčením hyperparathyroidismu při chronickém selhání ledvin. I. etiopatogeneze sekundárního hyperparathyroidismu, předoperační nálezy, indikace k parathyreoidektomii. Čas. Lék. čes., 128, 1989, s. 742-747.
24. Schmid, T., Müller, P., Spelsberg, F.: Parathyroidectomy after renal transplantation: a retrospective analysis of long-term outcome. Nephrol. Dial. Transplant., 12, 1997, s. 2393-2396.
25. Hargrove, G. M., Pasieka, J. L., Hanley, D. A., Murphy, M. B.: Short and long-term outcome of total parathyroidectomy with immediate autografting versus subtotal parathyroidectomy in patients with end-stage renal disease. Am. J. Nephrol., 19, 1999, s. 559-564.
26. Coen, G., Calabria, S., Bellinghieri, G. et al.: Parathyroidectomy in chronic renal failure: Short- and long-term results on parathyroid function, blood pressure and anemia. Nephron, 88, 2001, s. 149-155.
27. Rothmund, M., Wagner, P. K., Schark, C.: Subtotal parathyroidectomy versus total parathyroidectomy and autotransplantation in secondary hyperparathyroidism. A randomized trial. World J. Surg., 15, 1991, s. 745-750.
28. Gagné, E.-R., Urena, P., Leite-Silva, S. et al.: Short- and long-term efficacy of total parathyroidectomy with immediate autografting compared with subtotal parathyroidectomy in haemodialysis patients. J. Am. Soc. Nephrol., 3, 1992, s. 1008-1017.
29. Hampl, H., Steinmüller, T., Fröhling, P. et al.: Long-term results of total parathyroidectomy without autotransplantation in patients with and without renal failure. Miner. Electrolyte Metab., 25, 1999, s. 161 až 170.
30. Wagner, P. K., Seesko, H. G., Rothmund, M.: Replantation of cryopreserved human parathyroid tissue. World J. Surg., 15, 1991, s. 751-755.